首页> 美国卫生研究院文献>Journal of Virology >Silencing of both β-TrCP1 and HOS (β-TrCP2) Is Required To Suppress Human Immunodeficiency Virus Type 1 Vpu-Mediated CD4 Down-Modulation
【2h】

Silencing of both β-TrCP1 and HOS (β-TrCP2) Is Required To Suppress Human Immunodeficiency Virus Type 1 Vpu-Mediated CD4 Down-Modulation

机译:必须沉默β-TrCP1和HOS(β-TrCP2)才能抑制人类免疫缺陷病毒1型Vpu介导的CD4下调。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The human immunodeficiency virus type 1 (HIV-1) Vpu protein interacts with CD4 within the endoplasmic reticula of infected cells and targets CD4 for degradation through interaction with β-TrCP1. Mammals possess a homologue of β-TrCP1, HOS, which is also named β-TrCP2. We show by coimmunoprecipitation experiments that β-TrCP2 binds Vpu and is able to induce CD4 down-modulation as efficiently as β-TrCP1. In two different cell lines, HeLa CD4+ and Jurkat, Vpu-mediated CD4 down-modulation could not be reversed through the individual silencing of endogenous β-TrCP1 or β-TrCP2 but instead required the two genes to be silenced simultaneously.
机译:1型人类免疫缺陷病毒(HIV-1)Vpu蛋白与受感染细胞内质网中的CD4相互作用,并通过与β-TrCP1相互作用将CD4靶向降解。哺乳动物具有β-TrCP1,HOS的同源物,也称为β-TrCP2。我们通过共免疫沉淀实验表明,β-TrCP2结合Vpu,能够像β-TrCP1一样有效地诱导CD4下调。在两种不同的细胞系HeLa CD4 + 和Jurkat中,Vpu介导的CD4下调不能通过内源性β-TrCP1或β-TrCP2的单独沉默来逆转,而是需要两个基因同时保持沉默。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号